Abbott Laboratories (ABT) Forms $59.25 Double Top; Philip Morris International (PM) Sentiment Is 1.11

Abbott Laboratories (NYSE:ABT) Logo

Abbott Laboratories (ABT) formed double top with $64.58 target or 9.00% above today’s $59.25 share price. Abbott Laboratories (ABT) has $103.47 billion valuation. The stock increased 1.30% or $0.76 during the last trading session, reaching $59.25. About 537,260 shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 16, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Philip Morris International Inc (PM) investors sentiment increased to 1.11 in 2017 Q4. It’s up 0.14, from 0.97 in 2017Q3. The ratio is positive, as 602 funds increased and opened new positions, while 541 sold and reduced their holdings in Philip Morris International Inc. The funds in our database now have: 1.09 billion shares, down from 1.10 billion shares in 2017Q3. Also, the number of funds holding Philip Morris International Inc in top ten positions decreased from 58 to 47 for a decrease of 11. Sold All: 74 Reduced: 467 Increased: 493 New Position: 109.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It improved, as 52 investors sold Abbott Laboratories shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Barr E S & accumulated 6,943 shares. Clifford Swan Counsel Ltd holds 1.04% or 334,383 shares in its portfolio. Riggs Asset Managment Inc invested in 0.03% or 1,296 shares. Northside Mngmt Ltd Liability stated it has 9,503 shares. Cypress Capital holds 75,542 shares or 0.9% of its portfolio. Mackenzie holds 0% or 17,237 shares in its portfolio. Martingale Asset Limited Partnership has invested 0% in Abbott Laboratories (NYSE:ABT). Stonebridge Management invested in 18,826 shares. City Holding stated it has 50,193 shares. Aristotle Cap Mgmt Lc owns 90,336 shares or 0.04% of their US portfolio. Bridges Inv Management Incorporated has invested 0.29% in Abbott Laboratories (NYSE:ABT). Martin Tn has invested 1.02% in Abbott Laboratories (NYSE:ABT). Cubic Asset Management Limited Liability Corporation owns 0.54% invested in Abbott Laboratories (NYSE:ABT) for 34,272 shares. Architects holds 0.1% of its portfolio in Abbott Laboratories (NYSE:ABT) for 10,682 shares. Cibc Commercial Bank Usa invested 0.2% of its portfolio in Abbott Laboratories (NYSE:ABT).

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories has $90 highest and $4 lowest target. $63.81’s average target is 7.70% above currents $59.25 stock price. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) has “Overweight” rating given on Thursday, January 25 by JP Morgan. Wells Fargo maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, January 25. Wells Fargo has “Outperform” rating and $70 target. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Thursday, August 27 by Wells Fargo. The rating was maintained by Jefferies on Tuesday, March 15 with “Buy”. RBC Capital Markets maintained it with “Buy” rating and $67.0 target in Wednesday, January 24 report. Gabelli maintained Abbott Laboratories (NYSE:ABT) on Friday, July 21 with “Buy” rating. The company was maintained on Tuesday, September 5 by Jefferies. BTIG Research reinitiated it with “Buy” rating and $56 target in Wednesday, June 21 report. The company was downgraded on Friday, January 29 by William Blair. The firm has “Buy” rating given on Thursday, October 19 by Stifel Nicolaus.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on April, 18. They expect $0.58 EPS, up 20.83% or $0.10 from last year’s $0.48 per share. ABT’s profit will be $1.01 billion for 25.54 P/E if the $0.58 EPS becomes a reality. After $0.74 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts -21.62% negative EPS growth.

Since October 23, 2017, it had 1 buy, and 19 insider sales for $28.95 million activity. $2.69 million worth of Abbott Laboratories (NYSE:ABT) was sold by Ford Robert B on Tuesday, January 30. $71,970 worth of Abbott Laboratories (NYSE:ABT) shares were sold by Funck Robert E. Watkin Jared sold 996 shares worth $58,635. On Wednesday, January 31 Blaser Brian J sold $1.73 million worth of Abbott Laboratories (NYSE:ABT) or 27,733 shares. $3.36 million worth of stock was sold by Fussell Stephen R on Friday, February 16. Contreras Jaime also sold $375,381 worth of Abbott Laboratories (NYSE:ABT) shares. Salvadori Daniel Gesua Sive sold $1.56M worth of stock.

Cedar Rock Capital Ltd holds 27.09% of its portfolio in Philip Morris International Inc. for 10.80 million shares. Emerging Sovereign Group Llc owns 401,740 shares or 9.66% of their US portfolio. Moreover, Troy Asset Management Ltd has 9.57% invested in the company for 2.20 million shares. The United Kingdom-based Caledonia Investments Plc has invested 9.5% in the stock. Fayez Sarofim & Co, a Texas-based fund reported 15.26 million shares.

Since January 1, 0001, it had 0 insider buys, and 3 selling transactions for $18.32 million activity.

The stock increased 0.28% or $0.29 during the last trading session, reaching $102.14. About 402,937 shares traded. Philip Morris International Inc. (PM) has declined 13.93% since April 16, 2017 and is downtrending. It has underperformed by 25.48% the S&P500.

Philip Morris International Inc., through its subsidiaries, makes and sells cigarettes, other tobacco products, and other nicotine-containing products. The company has market cap of $158.77 billion. The Company’s portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. It has a 26.32 P/E ratio. The firm also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Jackpot in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia.

Ratings analysis reveals 40% of Philip Morris International’s analysts are positive. Out of 5 Wall Street analysts rating Philip Morris International, 2 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $96.0 while the high is $96.0. The stock’s average target of $96 is -6.01% below today’s ($102.14) share price. PM was included in 5 notes of analysts from September 12, 2016. Bank of America downgraded the shares of PM in report on Wednesday, January 4 to “Neutral” rating. Citigroup initiated the stock with “Neutral” rating in Tuesday, September 13 report. The firm has “Hold” rating by Jefferies given on Wednesday, September 21. The firm earned “Buy” rating on Monday, September 12 by Goldman Sachs. The rating was upgraded by CLSA on Monday, November 14 to “Buy”.

Philip Morris International Inc. (NYSE:PM) Institutional Positions Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: